Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CEU | Ann: Removal from Official list | 02/11/11 | 0 | 1.3K | |||
|
|||||||
CEU | Ann: CONNECTEAST SCHEME IMPLEMENTED | 26/10/11 | 0 | 1.4K | |||
|
|||||||
CEU | Ann: Horizon Roads Scheme to proceed on cash basi | 13/10/11 | 0 | 1.4K | |||
|
|||||||
CEU | Ann: Scheme Meetings - Chairman's address | 11/10/11 | 8 | 4.0K | |||
|
|||||||
CEU | Ann: EastLink Traffic and Revenue - September 201 | 06/10/11 | 0 | 1.2K | |||
|
|||||||
CEU | Ann: Suspension from Official Quotation close of | 05/10/11 | 0 | 795 | |||
|
|||||||
CEU | Ann: Horizon Roads Scheme becomes effective | 05/10/11 | 0 | 1.0K | |||
|
|||||||
CBA +CEU | Ann: Ceasing to be a substantial holder from CBA | 05/10/11 | 0 | 652 | |||
|
See All Discussions